Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinuclean DM Spray for acute sinusitis
NCT00747747Phase 4Completed
- Sponsor
- Galsor
- Start
- Nov 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Sinuclean DM in sinusitis (3 arms), sponsored by Galsor. Primary endpoint: Presence of Mucus in the Paranasal Sinuses at 2 weeks. Started Nov 2007; status: completed.
02
Drugs
Sinuclean DM
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT00747747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747747.